期刊文献+

多巴胺联合去甲肾上腺素对感染性休克患者肾脏功能的影响 被引量:13

Effect of dopamine combined with norepinephrine on the renal function in patients with septic shock
原文传递
导出
摘要 目的研究多巴胺与去甲肾上腺素联合应用对感染性休克患者肾脏功能的影响。方法选择1996年以来在我科ICU接受治疗的感染性休克患者87例,以去甲肾上腺素最大泵注速率分为3组:其中A组28例(0.5~0.9μg·kg-1·min-1),B组30例(1.0~1.5μg·kg-1·min-1), C组29例(1.6~2.0μg·kg-1·min-1)。测定记录所有患者的平均静脉压(MAP)、心率(HR)、尿量、血尿素氮(BUN)、肌酐(CRE)、尿白蛋白(U-ALB)和β2微球蛋白(Uβ2-MG)定量及APACHEⅢ评分。结果治疗前,3组患者均有低血压、心动过速和少尿,多数患者CRE、BUN、U-ALB、Uβ2-MG和APACHEⅢ评分高于正常值上限。经过抗休克治疗,所有患者的MAP、HR、尿量及BUN、CRE均恢复到正常范围,U-ALB、Uβ2-MG定量及APACHEⅢ评分也有所恢复,但仍高于正常。结论在感染性休克的治疗中,应以恢复脏器血流灌注为首要目标,以容量复苏为主,必要时辅以多巴胺、去甲肾上腺素等血管活性药物来维持循环稳定。 Objective To investigate the effects of dopamine and norepinephrine on the renal function in the patients with septic shock. Methods Eighty-seven patients with septic shock were divided into three groups (group A, B, C) according to the biggest infusing rate of norepinephrine, with the infusing rate of 0. 5 - 0.9, 1.0 - 1.5, 1.6 - 2. 0 μg·kg^-1·min^-1 , respectively. Mean arterial blood pressure (MAP), heart rate(HR), urine output, blood urea nitrogen( BUN), creatinine( CRE), urine albumin( U- ALB) and urine β2-microglubulin(Uβ2-MG) as well as APACHE m score in all the patients were detected. Results Before anti-shock therapy was given, hypotension, tachycardia and oliguria occurred in all the 87 patients, and CRE, BUN, U-ALB, Uβ2-MG and APACHE Ⅲ score were abnormal in most cases. With the anti-shock therapy, MAP, HR, urine output and BUN, CRE in all patients returned to normal levels gradually, and U-ALB, Uβ2-MG levels and APACHE m score also restored but still remained abnormal. Conclusions The first aim of treating septic shock should be restoring the organ blood supply, and based on volume resuscitation, dopamine, noradrenaline and other vasoactive drugs could be combined to maintain circulatory stability.
出处 《中华外科杂志》 CAS CSCD 北大核心 2006年第17期1206-1208,共3页 Chinese Journal of Surgery
关键词 多巴胺 去甲肾上腺素 休克 脓毒性 肾脏功能 Dopamine Norepinephrine Septic shock Renal function
  • 相关文献

参考文献14

  • 1Hurford WE,主编:危重症监测治疗手册.第3版.王俊科,郑斯聚,盛卓人,主译.沈阳:辽宁科学技术出版社,2001.124.
  • 2Boffa JJ,Arendshorst WJ.Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock.J Am Soc Nephrol,2005,16:117-124.
  • 3Holmes CL.Vasoactive drugs in the intensive care unit.Curr Opin Crit Care,2005,11:413-417.
  • 4Bellomo R,Giantomasso DD.Noradrenaline and the kidney:friends or foes? Crit Care,2001,5:294-298.
  • 5Schetz M.Vasopressors and the kidney.Blood Purif,2002,20:243 -251.
  • 6Lee RW,Di Giantomasso D,Mayp C,et al.Vasoactive drugs and the kidney.Best Pract Res Clin Anaesthesiol,2004,18:53-74.
  • 7Pereira CN,Machado FR,Guimaraes HP,et al.Hemodynamics and renal function during administration of low-dose dopamine in severely ill patients.Sao Paulo Med J,2004,122:141-146.
  • 8Friedrich JO,Adhikari N,Herridge MS,et al.Meta-analysis:lowdose dopamine increases urine output but does not prevent renal dysfunction or death.Ann Intern Med,2005,142:510-524.
  • 9Duarte H,Ormonde L,Lima F.The controversial use of dopamine in major vascular surgery.Rev Port Cir Cardiotorac Vasc,2004,11:213-216.
  • 10Girbes AR,Hoogenberg K.The use of dopamine and norepinephrine in the ICU.In:Yearbook of intensive care and emergency medicine.Vincent JL,ed.Berlin:Springer Verlag,1988.178-187.

共引文献9

同被引文献95

引证文献13

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部